Neurol Sci (2005) 26:32–39
DOI 10.1007/s10072-005-0379-8
DOI 10.1007/s10072-005-0379-8
Autoren:
J. Slawek, A. Bogucki, D. Reclawowicz
Abstract: Current antispastic medications are unsatisfacto-ry for spasticity treatment,but botulinum toxin type A(BTX-A) shows promise as a new therapeutic option. ….